plusbacin A3   Click here for help

GtoPdb Ligand ID: 11020

Comment: Plusbacin A3 was isolated from Pseudomonas sp. PB-6250 [3]. It acts as a peptidoglycan synthesis inhibitor in methicillin-resistant Staphylococcus aureus [2]. Plusbacin A3 can be chemically synthesised [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 33
Hydrogen bond donors 16
Rotatable bonds 34
Topological polar surface area 530.41
Molecular weight 1383.77
XLogP 7.64
No. Lipinski's rules broken 4
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCCCCCCCCC1OC(=O)[C@@H](NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@H](NC(=O)[C@H](N(C(=O)C1)C(=O)CC(CCCCCCCCCCC(C)C)O)[C@H](O)C)C)CC[C@@H]2O)CCCN=C(N)N)[C@H](C(=O)O)O)[C@@H](C(=O)O)O
Isomeric SMILES CCCCCCCCCCCC1OC(=O)[C@@H](NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@H](NC(=O)[C@H](N(C(=O)C1)C(=O)CC(CCCCCCCCCCC(C)C)O)[C@H](O)C)C)CC[C@@H]2O)CCCN=C(N)N)[C@H](C(=O)O)O)[C@@H](C(=O)O)O
InChI InChI=1S/C64H109N11O22/c1-6-7-8-9-10-11-16-19-22-26-40-34-46(82)75(45(81)33-39(78)25-21-18-15-13-12-14-17-20-24-36(2)3)49(38(5)77)56(87)68-37(4)59(90)73-31-28-43(79)50(73)57(88)69-41(27-23-30-67-64(65)66)54(85)71-47(52(83)61(92)93)55(86)70-42(35-76)60(91)74-32-29-44(80)51(74)58(89)72-48(63(96)97-40)53(84)62(94)95/h36-44,47-53,76-80,83-84H,6-35H2,1-5H3,(H,68,87)(H,69,88)(H,70,86)(H,71,85)(H,72,89)(H,92,93)(H,94,95)(H4,65,66,67)/t37-,38-,39?,40?,41+,42-,43+,44+,47-,48+,49-,50+,51+,52-,53+/m1/s1
InChI Key RRAOZJHXDSMGMH-LOKPQUDHSA-N
References
1. Katsuyama A, Paudel A, Panthee S, Hamamoto H, Kawakami T, Hojo H, Yakushiji F, Ichikawa S. (2017)
Total Synthesis and Antibacterial Investigation of Plusbacin A3.
Org Lett, 19 (14): 3771-3774. [PMID:28696114]
2. Maki H, Miura K, Yamano Y. (2001)
Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother, 45 (6): 1823-7. [PMID:11353632]
3. Shoji J, Hinoo H, Katayama T, Nakagawa Y, Ikenishi Y, Iwatani K, Yoshida T. (1992)
Structures of new peptide antibiotics, plusbacins A1-A4 and B1-B4.
J Antibiot, 45 (6): 824-31. [PMID:1500346]